United States· US:59651-685_7aed5da7-4693-4e11-ab51-ed24f76d879d

TOFACITINIB

A tofacitinib product containing tofacitinib citrate, registered in United States by Aurobindo Pharma Limited. The same ATC class is registered in 13 of our 19 countries.

ATC L04AF01

Checked against FDA National Drug Code directory (United States) on July 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about tofacitinib citrateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Tofacitinib is registered in 13 of 19 countries.

Countries holding a registration under ATC L04AF01 (tofacitinib), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
7 of them publish a price we can compare per daily dose

Search tofacitinib products by name

Tofacitinib · ATC L04AF01

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tofacitinib costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $1.99 in United States to $17.31 in Switzerland — a ×8.7 gap.

United States: $1.99 per daily dose (median across products in the class)
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Tofacitinib · price per daily dose (10 mg)

USD · FX 28 Sept 2026

CH Switzerland$17.31
US United States$1.99 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: TOFACITINIB CITRATE
Manufacturer: Aurobindo Pharma Limited
Country: United States (US)
ATC code: L04AF01
ATC class: Tofacitinib
Defined daily dose: 10 mg, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: July 26, 2026

Packs & prices · 1

ndc11
59651-685-30

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

512 interactions on record for tofacitinib.

Graded by severity as the source publishes them — 333 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check tofacitinib against other medicines How interaction checks work

Tofacitinib · interactions on record

512 records

333 severe
171 moderate
8 minor

Most severe, free to view

PrednisoloneA07EA01severe
HydrocortisoneA07EA02severe
PrednisoneA07EA03severe
BetamethasoneA07EA04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tofacitinib in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tofacitinib products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

Austria · Tofacitinib Devatis, Tofacitinib Stada
Bulgaria · Tофацитиниб Devatis
Denmark · Tofacitinib Accord, Tofacitinib Newbury
Spain · Tofacitinib Stada
Finland · Tofacitinib Devatis, Tofacitinib Stada
France · Tofacitinib Stada
United Kingdom (Northern Ireland) · Tofacitinib Amarox, Tofacitinib Brown & Burk Uk
Croatia · Tofacitinib Accord, Tofacitinib Stada
Iceland · Xeljanz
Liechtenstein · Xeljanz
Malta · Tofacitinib Stada
Netherlands · Tofacitinib Devatis, Tofacitinib Stada
Norway · Tofacitinib Accord, Tofacitinib Devatis
Portugal · Tofacitinib Bluepharma
Sweden · Tofacitinib Devatis, Tofacitinib Newbury

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/cfd6bd9d-6efc-4dc5-8e7c-64f7f572cc86
GET /v1/drugs/cfd6bd9d-6efc-4dc5-8e7c-64f7f572cc86?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "11",
  "substance": "TOFACITINIB CITRATE",
  "productndc": "59651-685",
  "dosage_form": "TABLET, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA218462",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about tofacitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console